NM_024675.4(PALB2):c.3008A>G (p.Asn1003Ser) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 14, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002435731.2

Allele description [Variation Report for NM_024675.4(PALB2):c.3008A>G (p.Asn1003Ser)]

NM_024675.4(PALB2):c.3008A>G (p.Asn1003Ser)

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.3008A>G (p.Asn1003Ser)

HGVS:

NC_000016.10:g.23621467T>C
NG_007406.1:g.24891A>G
NM_001407296.1:c.2948A>G
NM_001407297.1:c.2936A>G
NM_001407298.1:c.2846A>G
NM_001407299.1:c.3008A>G
NM_001407301.1:c.3008A>G
NM_001407302.1:c.2846A>G
NM_001407304.1:c.2123A>G
NM_001407305.1:c.2123A>G
NM_001407306.1:c.2123A>G
NM_001407307.1:c.1961A>G
NM_001407308.1:c.2123A>G
NM_001407309.1:c.2123A>G
NM_001407310.1:c.2123A>G
NM_001407311.1:c.2123A>G
NM_001407312.1:c.1220A>G
NM_001407313.1:c.1220A>G
NM_001407314.1:c.542A>G
NM_024675.4:c.3008A>GMANE SELECT
NP_001394225.1:p.Asn983Ser
NP_001394226.1:p.Asn979Ser
NP_001394227.1:p.Asn949Ser
NP_001394228.1:p.Asn1003Ser
NP_001394230.1:p.Asn1003Ser
NP_001394231.1:p.Asn949Ser
NP_001394233.1:p.Asn708Ser
NP_001394234.1:p.Asn708Ser
NP_001394235.1:p.Asn708Ser
NP_001394236.1:p.Asn654Ser
NP_001394237.1:p.Asn708Ser
NP_001394238.1:p.Asn708Ser
NP_001394239.1:p.Asn708Ser
NP_001394240.1:p.Asn708Ser
NP_001394241.1:p.Asn407Ser
NP_001394242.1:p.Asn407Ser
NP_001394243.1:p.Asn181Ser
NP_078951.2:p.Asn1003Ser
NP_078951.2:p.Asn1003Ser
LRG_308t1:c.3008A>G
LRG_308:g.24891A>G
LRG_308p1:p.Asn1003Ser
NC_000016.9:g.23632788T>C
NM_024675.3:c.3008A>G

Protein change:

N1003S

Molecular consequence:

NM_001407296.1:c.2948A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407297.1:c.2936A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407298.1:c.2846A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407299.1:c.3008A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407301.1:c.3008A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407302.1:c.2846A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407304.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407305.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407306.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407307.1:c.1961A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407308.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407309.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407310.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407311.1:c.2123A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407312.1:c.1220A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407313.1:c.1220A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001407314.1:c.542A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_024675.4:c.3008A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002750809	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Feb 14, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002750809

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Feb 14, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002750809.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.N1003S variant (also known as c.3008A>G), located in coding exon 10 of the PALB2 gene, results from an A to G substitution at nucleotide position 3008. The asparagine at codon 1003 is replaced by serine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine